223 related articles for article (PubMed ID: 30660821)
1. Oleoylethanolamide inhibits glial activation via moudulating PPARα and promotes motor function recovery after brain ischemia.
Luo D; Zhang Y; Yuan X; Pan Y; Yang L; Zhao Y; Zhuo R; Chen C; Peng L; Li W; Jin X; Zhou Y
Pharmacol Res; 2019 Mar; 141():530-540. PubMed ID: 30660821
[TBL] [Abstract][Full Text] [Related]
2. Oleoylethanolamide attenuates apoptosis by inhibiting the TLR4/NF-κB and ERK1/2 signaling pathways in mice with acute ischemic stroke.
Zhou H; Yang WS; Li Y; Ren T; Peng L; Guo H; Liu JF; Zhou Y; Zhao Y; Yang LC; Jin X
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):77-84. PubMed ID: 27738712
[TBL] [Abstract][Full Text] [Related]
3. Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α.
Zhou Y; Yang L; Ma A; Zhang X; Li W; Yang W; Chen C; Jin X
Neuropharmacology; 2012 Aug; 63(2):242-9. PubMed ID: 22480617
[TBL] [Abstract][Full Text] [Related]
4. Chronic oleoylethanolamide treatment improves spatial cognitive deficits through enhancing hippocampal neurogenesis after transient focal cerebral ischemia.
Yang LC; Guo H; Zhou H; Suo DQ; Li WJ; Zhou Y; Zhao Y; Yang WS; Jin X
Biochem Pharmacol; 2015 Apr; 94(4):270-81. PubMed ID: 25748831
[TBL] [Abstract][Full Text] [Related]
5. Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice.
Yu GL; Wei EQ; Wang ML; Zhang WP; Zhang SH; Weng JQ; Chu LS; Fang SH; Zhou Y; Chen Z; Zhang Q; Zhang LH
Brain Res; 2005 Aug; 1053(1-2):116-25. PubMed ID: 16051204
[TBL] [Abstract][Full Text] [Related]
6. Salidroside Inhibits Reactive Astrogliosis and Glial Scar Formation in Late Cerebral Ischemia via the Akt/GSK-3β Pathway.
Dong C; Wen S; Zhao S; Sun S; Zhao S; Dong W; Han P; Chen Q; Gong T; Chen W; Liu W; Liu X
Neurochem Res; 2021 Apr; 46(4):755-769. PubMed ID: 33389472
[TBL] [Abstract][Full Text] [Related]
7. Sevoflurane postconditioning attenuates reactive astrogliosis and glial scar formation after ischemia-reperfusion brain injury.
Zhu YM; Gao X; Ni Y; Li W; Kent TA; Qiao SG; Wang C; Xu XX; Zhang HL
Neuroscience; 2017 Jul; 356():125-141. PubMed ID: 28501505
[TBL] [Abstract][Full Text] [Related]
8. Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARα/γ dual agonist, protects against ischemia-induced brain damage in mice by inhibiting inflammatory responses.
Li Y; Xu L; Zeng K; Xu Z; Suo D; Peng L; Ren T; Sun Z; Yang W; Jin X; Yang L
Brain Behav Immun; 2017 Nov; 66():289-301. PubMed ID: 28736035
[TBL] [Abstract][Full Text] [Related]
9. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
[TBL] [Abstract][Full Text] [Related]
10. Oleoylethanolamide ameliorates motor dysfunction through PPARα-mediates oligodendrocyte differentiation and white matter integrity after ischemic stroke.
Zhuo R; Song Z; Wang Y; Zhu M; Liu F; Lin P; Rao R; Zhou Y; Zhao Y; Fan Z; Cui L; Liu H; Li J; Li Y; Guo H; Cai CF; Yang L
Phytother Res; 2023 Nov; 37(11):5341-5353. PubMed ID: 37700535
[TBL] [Abstract][Full Text] [Related]
11. Oleoylethanolamide stabilizes atherosclerotic plaque through regulating macrophage polarization via AMPK-PPARα pathway.
Chen Z; Zhuo R; Zhao Y; Yang L; Zhou Y; Cheng X; Peng L; Jin X; Wang Y
Biochem Biophys Res Commun; 2020 Apr; 524(2):308-316. PubMed ID: 31987499
[TBL] [Abstract][Full Text] [Related]
12. Oleoylethanolamide alleviates macrophage formation via AMPK/PPARα/STAT3 pathway.
Zhao Y; Yan L; Peng L; Huang X; Zhang G; Chen B; Ren J; Zhou Y; Yang L; Peng L; Jin X; Wang Y
Pharmacol Rep; 2018 Dec; 70(6):1185-1194. PubMed ID: 30336422
[TBL] [Abstract][Full Text] [Related]
13. Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells.
Chen L; Li L; Chen J; Li L; Zheng Z; Ren J; Qiu Y
Oncotarget; 2015 Dec; 6(40):42530-40. PubMed ID: 26729705
[TBL] [Abstract][Full Text] [Related]
14. The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice.
Cluny NL; Keenan CM; Lutz B; Piomelli D; Sharkey KA
Neurogastroenterol Motil; 2009 Apr; 21(4):420-9. PubMed ID: 19140957
[TBL] [Abstract][Full Text] [Related]
15. Oleoylethanolamide Delays the Dysfunction and Death of Purkinje Cells and Ameliorates Behavioral Defects in a Mouse Model of Cerebellar Neurodegeneration.
Pérez-Martín E; Muñoz-Castañeda R; Moutin MJ; Ávila-Zarza CA; Muñoz-Castañeda JM; Del Pilar C; Alonso JR; Andrieux A; Díaz D; Weruaga E
Neurotherapeutics; 2021 Jul; 18(3):1748-1767. PubMed ID: 33829414
[TBL] [Abstract][Full Text] [Related]
16. URB597 exerts neuroprotective effects against transient brain ischemia injury in mice by regulating autophagic flux and necroptosis.
Yuan X; Ye W; Chen L; Luo D; Zhou L; Qiu Y; Zhuo R; Zhao Y; Peng L; Yang L; Jin X; Zhou Y
Eur J Pharmacol; 2023 Oct; 957():175982. PubMed ID: 37572942
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Naotaifang on microglial polarization and glial scar following cerebral ischemia reperfusion injury].
Liu JY; Zhang WL; Liao J; Hu LJ; Wang GZ; Ge JW; Mei ZG
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):989-999. PubMed ID: 38621906
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of saffron on the late cerebral ischemia injury through inhibiting astrogliosis and glial scar formation in rats.
Zhong K; Wang RX; Qian XD; Yu P; Zhu XY; Zhang Q; Ye YL
Biomed Pharmacother; 2020 Jun; 126():110041. PubMed ID: 32113053
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid attenuates ischemic injury-induced activation of glial cells and inflammatory factors in a rat stroke model.
Kang JB; Son HK; Shah MA; Koh PO
PLoS One; 2024; 19(3):e0300072. PubMed ID: 38527023
[TBL] [Abstract][Full Text] [Related]
20. Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons.
Galan-Rodriguez B; Suarez J; Gonzalez-Aparicio R; Bermudez-Silva FJ; Maldonado R; Robledo P; Rodriguez de Fonseca F; Fernandez-Espejo E
Neuropharmacology; 2009 Mar; 56(3):653-64. PubMed ID: 19070629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
